HELX

Category	Global or ExUS Equities - Industry Sector
Sponsor	Franklin Templeton
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	0.14 (0.34%)
Dividend Ex-Date	Dec 30, 2025
Dividend Gr. 3/5Y	- 95.56%
Expense	0.50%
Inverse/Leveraged
IPO	Feb 27, 2020

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	Yes / Yes

Tags	Global
Tags	equity
Tags	healthcare
Tags	genomics
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	-2.39%
SMA50	-1.77%
SMA200	11.56%

Return% 1Y	21.09%
Return% 3Y	18.30%
Return% 5Y	-4.51%
Return% 10Y
Return% SI
Flows% 1M	14.13%
Flows% 3M	6.47%
Flows% YTD	31.04%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	71
AUM	33.66M
NAV/sh
52W High	46.22 -8.71%
52W Low	31.24 35.06%
Volatility	2.49% 1.32%
ATR (14)	1.01
RSI (14)	44.70
Beta	0.98
Rel Volume	1.08
Avg Volume	5.79K
Volume	6,241

Perf Week	-6.75%
Perf Month	0.82%
Perf Quarter	1.11%
Perf Half Y	25.48%
Perf YTD	16.22%
Perf Year	21.40%
Perf 3Y	58.12%
Perf 5Y	-16.21%
Perf 10Y	-
Prev Close	42.04
Price	42.19
Change %	0.37%

Nov-25-25 03:44AM	The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI (Zacks)
Nov-24-25 10:00AM	Best-Performing ETFs of Last Week: Healthcare Rules (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
05:45AM	Loading…
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.44%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Jul-16-21 11:19AM	Blockchain will be hugely disruptive to the finance industry: Jenny Johnson (Yahoo Finance Video)
Jan-14-21 09:15AM	Franklin Adds To Thematic ETF Line (ETF.com)
08:00AM	Loading…
Oct-05-20 08:00AM	Franklin Templeton Gives Matt Moberg Three New Funds To Run (Investor's Business Daily)

Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

open in yahoo | open in marketwatch | open in google

Franklin Genomic Advancements ETF

Upgrade your Finviz experience